10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Identifying diseases-related metabolites using random walk

      research-article
      1 , 1 , 1 , 1 , , 2 , , 3 ,
      BMC Bioinformatics
      BioMed Central
      Biological Ontologies and Knowledge bases workshop at IEEE BIBM 2017
      14 November 2017
      Metabolites, Similarity of diseases, Similarity of metabolites, Random walk, InfDisSim, MISIM

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Metabolites disrupted by abnormal state of human body are deemed as the effect of diseases. In comparison with the cause of diseases like genes, these markers are easier to be captured for the prevention and diagnosis of metabolic diseases. Currently, a large number of metabolic markers of diseases need to be explored, which drive us to do this work.

          Methods

          The existing metabolite-disease associations were extracted from Human Metabolome Database (HMDB) using a text mining tool NCBO annotator as priori knowledge. Next we calculated the similarity of a pair-wise metabolites based on the similarity of disease sets of them. Then, all the similarities of metabolite pairs were utilized for constructing a weighted metabolite association network (WMAN). Subsequently, the network was utilized for predicting novel metabolic markers of diseases using random walk.

          Results

          Totally, 604 metabolites and 228 diseases were extracted from HMDB. From 604 metabolites, 453 metabolites are selected to construct the WMAN, where each metabolite is deemed as a node, and the similarity of two metabolites as the weight of the edge linking them. The performance of the network is validated using the leave one out method. As a result, the high area under the receiver operating characteristic curve (AUC) (0.7048) is achieved. The further case studies for identifying novel metabolites of diabetes mellitus were validated in the recent studies.

          Conclusion

          In this paper, we presented a novel method for prioritizing metabolite-disease pairs. The superior performance validates its reliability for exploring novel metabolic markers of diseases.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: not found

          Metabolomics: a global biochemical approach to drug response and disease.

          Metabolomics is the study of metabolism at the global level. This rapidly developing new discipline has important potential implications for pharmacologic science. The concept that metabolic state is representative of the overall physiologic status of the organism lies at the heart of metabolomics. Metabolomic studies capture global biochemical events by assaying thousands of small molecules in cells, tissues, organs, or biological fluids-followed by the application of informatic techniques to define metabolomic signatures. Metabolomic studies can lead to enhanced understanding of disease mechanisms and to new diagnostic markers as well as enhanced understanding of mechanisms for drug or xenobiotic effect and increased ability to predict individual variation in drug response phenotypes (pharmacometabolomics). This review outlines the conceptual basis for metabolomics as well as analytical and informatic techniques used to study the metabolome and to define metabolomic signatures. It also highlights potential metabolomic applications to pharmacology and clinical pharmacology.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Next-generation sequencing platforms.

            Automated DNA sequencing instruments embody an elegant interplay among chemistry, engineering, software, and molecular biology and have built upon Sanger's founding discovery of dideoxynucleotide sequencing to perform once-unfathomable tasks. Combined with innovative physical mapping approaches that helped to establish long-range relationships between cloned stretches of genomic DNA, fluorescent DNA sequencers produced reference genome sequences for model organisms and for the reference human genome. New types of sequencing instruments that permit amazing acceleration of data-collection rates for DNA sequencing have been developed. The ability to generate genome-scale data sets is now transforming the nature of biological inquiry. Here, I provide an historical perspective of the field, focusing on the fundamental developments that predated the advent of next-generation sequencing instruments and providing information about how these instruments work, their application to biological research, and the newest types of sequencers that can extract data from single DNA molecules.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              iMAT: an integrative metabolic analysis tool.

              iMAT is an Integrative Metabolic Analysis Tool, enabling the integration of transcriptomic and proteomic data with genome-scale metabolic network models to predict enzymes' metabolic flux, based on the method previously described by Shlomi et al. The prediction of metabolic fluxes based on high-throughput molecular data sources could help to advance our understanding of cellular metabolism, since current experimental approaches are limited to measuring fluxes through merely a few dozen enzymes. http://imat.cs.tau.ac.il/.
                Bookmark

                Author and article information

                Contributors
                huyang@hit.edu.cn
                zty2009@hit.edu.cn
                mayazhang1992@hit.edu.cn
                tianyi.zang@hit.edu.cn
                zhangjun13902003@163.com
                liangcheng@hrbmu.edu.cn
                Conference
                BMC Bioinformatics
                BMC Bioinformatics
                BMC Bioinformatics
                BioMed Central (London )
                1471-2105
                11 April 2018
                11 April 2018
                2018
                : 19
                Issue : Suppl 5 Issue sponsor : Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.
                : 116
                Affiliations
                [1 ]ISNI 0000 0001 0193 3564, GRID grid.19373.3f, School of Life Science and Technology, Department of Computer Science and Technology, , Harbin Institute of Technology, ; Harbin, 150001 People’s Republic of China
                [2 ]Department of rehabilitation, Heilongjiang Province Land Reclamation Headquarters General Hospital, Harbin, 150001 People’s Republic of China
                [3 ]ISNI 0000 0001 2204 9268, GRID grid.410736.7, College of Bioinformatics Science and Technology, , Harbin Medical University, ; Harbin, 150001 China
                Article
                2098
                10.1186/s12859-018-2098-1
                5907145
                29671398
                89e2ea72-b942-48c8-a392-215033189788
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                Biological Ontologies and Knowledge bases workshop at IEEE BIBM 2017
                Kansas City, MO, USA
                14 November 2017
                History
                Categories
                Research
                Custom metadata
                © The Author(s) 2018

                Bioinformatics & Computational biology
                metabolites,similarity of diseases,similarity of metabolites,random walk,infdissim,misim

                Comments

                Comment on this article